Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,522 | -81,489 | -56,938 | -26,795 | -84,547 |
| Depreciation Amortization | 1,221 | 942 | 760 | 408 | 605 |
| Accounts payable and accrued liabilities | 64 | -4,662 | -4,149 | -5,816 | 7,163 |
| Other Working Capital | 3,497 | -2,575 | 1,899 | -5,362 | 9,522 |
| Other Operating Activity | 11,181 | 11,659 | 8,520 | 8,108 | 1,160 |
| Operating Cash Flow | $-98,559 | $-76,125 | $-49,908 | $-29,457 | $-66,097 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -361 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -142,821 | -56,245 | -39,314 | -26,710 | -143,810 |
| Sale Of Investment | 164,480 | 136,447 | 72,635 | 19,000 | N/A |
| Investing Cash Flow | $21,298 | $80,202 | $33,321 | $-7,710 | $-143,810 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 272,335 | 109,429 | 577 | 129 | 150,581 |
| Financing Cash Flow | $272,335 | $109,429 | $577 | $129 | $150,581 |
| Beginning Cash Position | 66,373 | 66,373 | 66,373 | 66,373 | 125,699 |
| End Cash Position | 261,447 | 179,879 | 50,363 | 29,335 | 66,373 |
| Net Cash Flow | $195,074 | $113,506 | $-16,010 | $-37,038 | $-59,326 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,559 | -76,125 | -49,908 | -29,457 | -66,097 |
| Capital Expenditure | -361 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -98,920 | -76,125 | -49,908 | -29,457 | -66,097 |